OBJECTIVES: To evaluate the association of USA300 genotype with outcomes in persons with MRSA bacteremia and examine the epidemiology of MRSA bacteremia over time. METHODS: Population-based surveillance for MRSA bacteremia was performed in 8-county Atlanta from 2005 to 2008. Cases of MRSA bacteremia were classified as healthcare-associated hospital-onset (HAHO), healthcare-associated community-onset (HACO), or community-associated (CA) disease. A survival analysis was performed on a nested cohort of cases with isolates characterized by pulse field gel electrophoresis (PFGE). RESULTS: 4344 MRSA bacteremia cases were identified; 2579 (59.4%) HACO, 1144 (26.3%) HAHO; and 601 (13.8%) CA. Overall incidence rates of MRSA bacteremia declined from 33.9/100,000 in 2005-24.8/100,000 in 2008. Rates were highest in persons ≥ 65 years, blacks, males, and persons with AIDS. In multivariate analysis of 1104 cases, USA300 genotype was associated with increased in-hospital mortality (HR 1.63, 95% CI 1.19-2.23). USA300 strains were also associated with increased mortality when compared to USA100 strains (HR 1.79, 95% CI 1.24-2.58). CONCLUSIONS: MRSA bacteremia incidence declined over 4 years but CA disease rates remained stable. Persons with HIV, the elderly, and blacks were disproportionately affected. Bacteremia due to USA300 MRSA strains was associated with increased mortality, suggesting that USA300 strains may be more virulent.
OBJECTIVES: To evaluate the association of USA300 genotype with outcomes in persons with MRSA bacteremia and examine the epidemiology of MRSA bacteremia over time. METHODS: Population-based surveillance for MRSA bacteremia was performed in 8-county Atlanta from 2005 to 2008. Cases of MRSA bacteremia were classified as healthcare-associated hospital-onset (HAHO), healthcare-associated community-onset (HACO), or community-associated (CA) disease. A survival analysis was performed on a nested cohort of cases with isolates characterized by pulse field gel electrophoresis (PFGE). RESULTS: 4344 MRSA bacteremia cases were identified; 2579 (59.4%) HACO, 1144 (26.3%) HAHO; and 601 (13.8%) CA. Overall incidence rates of MRSA bacteremia declined from 33.9/100,000 in 2005-24.8/100,000 in 2008. Rates were highest in persons ≥ 65 years, blacks, males, and persons with AIDS. In multivariate analysis of 1104 cases, USA300 genotype was associated with increased in-hospital mortality (HR 1.63, 95% CI 1.19-2.23). USA300 strains were also associated with increased mortality when compared to USA100 strains (HR 1.79, 95% CI 1.24-2.58). CONCLUSIONS:MRSA bacteremia incidence declined over 4 years but CA disease rates remained stable. Persons with HIV, the elderly, and blacks were disproportionately affected. Bacteremia due to USA300 MRSA strains was associated with increased mortality, suggesting that USA300 strains may be more virulent.
Authors: A Soriano; J A Martínez; J Mensa; F Marco; M Almela; A Moreno-Martínez; F Sánchez; I Muñoz; M T Jiménez de Anta; E Soriano Journal: Clin Infect Dis Date: 2000-02 Impact factor: 9.079
Authors: Timothy S Naimi; Kathleen H LeDell; Kathryn Como-Sabetti; Stephanie M Borchardt; David J Boxrud; Jerome Etienne; Susan K Johnson; Francois Vandenesch; Scott Fridkin; Carol O'Boyle; Richard N Danila; Ruth Lynfield Journal: JAMA Date: 2003-12-10 Impact factor: 56.272
Authors: Henry C Baggett; Thomas W Hennessy; Karen Rudolph; Dana Bruden; Alisa Reasonover; Alan Parkinson; Rachel Sparks; Rodney M Donlan; Patricia Martinez; Kanokporn Mongkolrattanothai; Jay C Butler Journal: J Infect Dis Date: 2004-04-16 Impact factor: 5.226
Authors: Linda K McDougal; Christine D Steward; George E Killgore; Jasmine M Chaitram; Sigrid K McAllister; Fred C Tenover Journal: J Clin Microbiol Date: 2003-11 Impact factor: 5.948
Authors: Hilmar Wisplinghoff; Tammy Bischoff; Sandra M Tallent; Harald Seifert; Richard P Wenzel; Michael B Edmond Journal: Clin Infect Dis Date: 2004-07-15 Impact factor: 9.079
Authors: Craig E Zinderman; Byron Conner; Mark A Malakooti; James E LaMar; Adam Armstrong; Bruce K Bohnker Journal: Emerg Infect Dis Date: 2004-05 Impact factor: 6.883
Authors: Kristen M Kreisel; O Colin Stine; J Kristie Johnson; Eli N Perencevich; Michelle D Shardell; Alan J Lesse; Fred M Gordin; Michael W Climo; Mary-Claire Roghmann Journal: Diagn Microbiol Infect Dis Date: 2011-05-10 Impact factor: 2.803
Authors: Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell Journal: Clin Microbiol Rev Date: 2012-04 Impact factor: 26.132
Authors: S J Eells; J A McKinnell; A A Wang; N L Green; D Whang; P O'Hara; M L Brown; L G Miller Journal: Epidemiol Infect Date: 2012-12-06 Impact factor: 2.451
Authors: Warren E Rose; Sanjay K Shukla; Andrew D Berti; Mary S Hayney; Kelsey M Henriquez; Andrea Ranzoni; Matthew A Cooper; Richard A Proctor; Victor Nizet; George Sakoulas Journal: Clin Infect Dis Date: 2017-05-15 Impact factor: 9.079